Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2022
- QYR1434280
- 105 Pages
- August 2017
- Medical Devices
Bristol-Myers Squibb Company
Fujifilm Holding Corporation
Astellas Pharma Inc.
Fate Therapeutics, Inc.
Aastrom Biosciences, Inc.
ViaCyte, Inc.
Celgene Corporation
Japan Tissue Engineering Co., Ltd.
Organogenesis Inc.
Acelity Holdings, Inc.
StemCells, Inc.
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Induced Pluripotent Stem Cells can be split into
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Market segment by Application, Induced Pluripotent Stem Cells can be split into
Academic Research
Toxicity Screening
Regenerative Medicine
Drug Development and Discovery
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2022
1 Industry Overview of Induced Pluripotent Stem Cells
1.1 Induced Pluripotent Stem Cells Market Overview
1.1.1 Induced Pluripotent Stem Cells Product Scope
1.1.2 Market Status and Outlook
1.2 Global Induced Pluripotent Stem Cells Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Induced Pluripotent Stem Cells Market by Type
1.3.1 Hepatocytes
1.3.2 Fibroblasts
1.3.3 Keratinocytes
1.3.4 Amniotic Cells
1.4 Induced Pluripotent Stem Cells Market by End Users/Application
1.4.1 Academic Research
1.4.2 Toxicity Screening
1.4.3 Regenerative Medicine
1.4.4 Drug Development and Discovery
2 Global Induced Pluripotent Stem Cells Competition Analysis by Players
2.1 Induced Pluripotent Stem Cells Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Bristol-Myers Squibb Company
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Induced Pluripotent Stem Cells Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Fujifilm Holding Corporation
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Induced Pluripotent Stem Cells Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Astellas Pharma Inc.
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Induced Pluripotent Stem Cells Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Fate Therapeutics, Inc.
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Induced Pluripotent Stem Cells Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Aastrom Biosciences, Inc.
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Induced Pluripotent Stem Cells Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 ViaCyte, Inc.
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Induced Pluripotent Stem Cells Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Celgene Corporation
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Induced Pluripotent Stem Cells Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Japan Tissue Engineering Co., Ltd.
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Induced Pluripotent Stem Cells Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Organogenesis Inc.
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Induced Pluripotent Stem Cells Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Acelity Holdings, Inc.
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Induced Pluripotent Stem Cells Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 StemCells, Inc.
4 Global Induced Pluripotent Stem Cells Market Size by Type and Application (2012-2017)
4.1 Global Induced Pluripotent Stem Cells Market Size by Type (2012-2017)
4.2 Global Induced Pluripotent Stem Cells Market Size by Application (2012-2017)
4.3 Potential Application of Induced Pluripotent Stem Cells in Future
4.4 Top Consumer/End Users of Induced Pluripotent Stem Cells
5 United States Induced Pluripotent Stem Cells Development Status and Outlook
5.1 United States Induced Pluripotent Stem Cells Market Size (2012-2017)
5.2 United States Induced Pluripotent Stem Cells Market Size and Market Share by Players (2016 and 2017)
6 EU Induced Pluripotent Stem Cells Development Status and Outlook
6.1 EU Induced Pluripotent Stem Cells Market Size (2012-2017)
6.2 EU Induced Pluripotent Stem Cells Market Size and Market Share by Players (2016 and 2017)
7 Japan Induced Pluripotent Stem Cells Development Status and Outlook
7.1 Japan Induced Pluripotent Stem Cells Market Size (2012-2017)
7.2 Japan Induced Pluripotent Stem Cells Market Size and Market Share by Players (2016 and 2017)
8 China Induced Pluripotent Stem Cells Development Status and Outlook
8.1 China Induced Pluripotent Stem Cells Market Size (2012-2017)
8.2 China Induced Pluripotent Stem Cells Market Size and Market Share by Players (2016 and 2017)
9 India Induced Pluripotent Stem Cells Development Status and Outlook
9.1 India Induced Pluripotent Stem Cells Market Size (2012-2017)
9.2 India Induced Pluripotent Stem Cells Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Induced Pluripotent Stem Cells Development Status and Outlook
10.1 Southeast Asia Induced Pluripotent Stem Cells Market Size (2012-2017)
10.2 Southeast Asia Induced Pluripotent Stem Cells Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Induced Pluripotent Stem Cells Market Size (Value) by Regions (2017-2022)
11.1.1 United States Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
11.1.2 EU Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
11.1.3 Japan Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
11.1.4 China Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
11.1.5 India Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Induced Pluripotent Stem Cells Revenue and Growth Rate (2017-2022)
11.2 Global Induced Pluripotent Stem Cells Market Size (Value) by Type (2017-2022)
11.3 Global Induced Pluripotent Stem Cells Market Size by Application (2017-2022)
12 Induced Pluripotent Stem Cells Market Dynamics
12.1 Induced Pluripotent Stem Cells Market Opportunities
12.2 Induced Pluripotent Stem Cells Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Induced Pluripotent Stem Cells Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Induced Pluripotent Stem Cells Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Figure Induced Pluripotent Stem Cells Product Scope
Figure Global Induced Pluripotent Stem Cells Market Size (Million USD) (2012-2017)
Table Global Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Induced Pluripotent Stem Cells Market Share by Regions in 2016
Figure United States Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Induced Pluripotent Stem Cells Market Share by Type in 2016
Figure Hepatocytes Market Size (Million USD) and Growth Rate (2012-2017)
Figure Fibroblasts Market Size (Million USD) and Growth Rate (2012-2017)
Figure Keratinocytes Market Size (Million USD) and Growth Rate (2012-2017)
Figure Amniotic Cells Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Induced Pluripotent Stem Cells Market Share by Application in 2016
Table Key Downstream Customer in Academic Research
Figure Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate in Academic Research (2012-2017)
Table Key Downstream Customer in Toxicity Screening
Figure Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate in Toxicity Screening (2012-2017)
Table Key Downstream Customer in Regenerative Medicine
Figure Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate in Regenerative Medicine (2012-2017)
Table Key Downstream Customer in Drug Development and Discovery
Figure Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate in Drug Development and Discovery (2012-2017)
Table Induced Pluripotent Stem Cells Market Size (Million USD) by Players (2016 and 2017)
Figure Induced Pluripotent Stem Cells Market Size Share by Players in 2016
Figure Induced Pluripotent Stem Cells Market Size Share by Players in 2017
Table Bristol-Myers Squibb Company Basic Information List
Table Induced Pluripotent Stem Cells Business Revenue (Million USD) of Bristol-Myers Squibb Company (2012-2017)
Figure Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Business Revenue Market Share in 2016
Table Fujifilm Holding Corporation Basic Information List
Table Induced Pluripotent Stem Cells Business Revenue (Million USD) of Fujifilm Holding Corporation (2012-2017)
Figure Fujifilm Holding Corporation Induced Pluripotent Stem Cells Business Revenue Market Share in 2016
Table Astellas Pharma Inc. Basic Information List
Table Induced Pluripotent Stem Cells Business Revenue (Million USD) of Astellas Pharma Inc. (2012-2017)
Figure Astellas Pharma Inc. Induced Pluripotent Stem Cells Business Revenue Market Share in 2016
Table Fate Therapeutics, Inc. Basic Information List
Table Induced Pluripotent Stem Cells Business Revenue (Million USD) of Fate Therapeutics, Inc. (2012-2017)
Figure Fate Therapeutics, Inc. Induced Pluripotent Stem Cells Business Revenue Market Share in 2016
Table Aastrom Biosciences, Inc. Basic Information List
Table Induced Pluripotent Stem Cells Business Revenue (Million USD) of Aastrom Biosciences, Inc. (2012-2017)
Figure Aastrom Biosciences, Inc. Induced Pluripotent Stem Cells Business Revenue Market Share in 2016
Table ViaCyte, Inc. Basic Information List
Table Induced Pluripotent Stem Cells Business Revenue (Million USD) of ViaCyte, Inc. (2012-2017)
Figure ViaCyte, Inc. Induced Pluripotent Stem Cells Business Revenue Market Share in 2016
Table Celgene Corporation Basic Information List
Table Induced Pluripotent Stem Cells Business Revenue (Million USD) of Celgene Corporation (2012-2017)
Figure Celgene Corporation Induced Pluripotent Stem Cells Business Revenue Market Share in 2016
Table Japan Tissue Engineering Co., Ltd. Basic Information List
Table Induced Pluripotent Stem Cells Business Revenue (Million USD) of Japan Tissue Engineering Co., Ltd. (2012-2017)
Figure Japan Tissue Engineering Co., Ltd. Induced Pluripotent Stem Cells Business Revenue Market Share in 2016
Table Organogenesis Inc. Basic Information List
Table Induced Pluripotent Stem Cells Business Revenue (Million USD) of Organogenesis Inc. (2012-2017)
Figure Organogenesis Inc. Induced Pluripotent Stem Cells Business Revenue Market Share in 2016
Table Acelity Holdings, Inc. Basic Information List
Table Induced Pluripotent Stem Cells Business Revenue (Million USD) of Acelity Holdings, Inc. (2012-2017)
Figure Acelity Holdings, Inc. Induced Pluripotent Stem Cells Business Revenue Market Share in 2016
Table StemCells, Inc. Basic Information List
Table Induced Pluripotent Stem Cells Business Revenue (Million USD) of StemCells, Inc. (2012-2017)
Figure StemCells, Inc. Induced Pluripotent Stem Cells Business Revenue Market Share in 2016
Table Global Induced Pluripotent Stem Cells Market Size (Million USD) by Type (2012-2017)
Figure Global Induced Pluripotent Stem Cells Market Size Share by Type in 2012
Figure Global Induced Pluripotent Stem Cells Market Size Share by Type in 2013
Figure Global Induced Pluripotent Stem Cells Market Size Share by Type in 2014
Figure Global Induced Pluripotent Stem Cells Market Size Share by Type in 2015
Figure Global Induced Pluripotent Stem Cells Market Size Share by Type in 2016
Figure Global Induced Pluripotent Stem Cells Market Size Share by Type in 2017
Table Global Induced Pluripotent Stem Cells Market Size (Million USD) by Application (2012-2017)
Figure Global Induced Pluripotent Stem Cells Market Size (Million USD) by Application in 2012
Figure Global Induced Pluripotent Stem Cells Market Size (Million USD) by Application in 2013
Figure Global Induced Pluripotent Stem Cells Market Size (Million USD) by Application in 2014
Figure Global Induced Pluripotent Stem Cells Market Size (Million USD) by Application in 2015
Figure Global Induced Pluripotent Stem Cells Market Size (Million USD) by Application in 2016
Figure Global Induced Pluripotent Stem Cells Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Induced Pluripotent Stem Cells
Figure United States Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Induced Pluripotent Stem Cells Market Size (Million USD) by Players (2012-2017)
Figure United States Induced Pluripotent Stem Cells Market Size Share by Players in 2016
Figure United States Induced Pluripotent Stem Cells Market Size Share by Players in 2017
Figure EU Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Induced Pluripotent Stem Cells Market Size (Million USD) by Players (2012-2017)
Figure EU Induced Pluripotent Stem Cells Market Size Share by Players in 2016
Figure EU Induced Pluripotent Stem Cells Market Size Share by Players in 2017
Figure Japan Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Induced Pluripotent Stem Cells Market Size (Million USD) by Players (2012-2017)
Figure Japan Induced Pluripotent Stem Cells Market Size Share by Players in 2016
Figure Japan Induced Pluripotent Stem Cells Market Size Share by Players in 2017
Figure China Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Induced Pluripotent Stem Cells Market Size (Million USD) by Players (2012-2017)
Figure China Induced Pluripotent Stem Cells Market Size Share by Players in 2016
Figure China Induced Pluripotent Stem Cells Market Size Share by Players in 2017
Figure India Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Induced Pluripotent Stem Cells Market Size (Million USD) by Players (2012-2017)
Figure India Induced Pluripotent Stem Cells Market Size Share by Players in 2016
Figure India Induced Pluripotent Stem Cells Market Size Share by Players in 2017
Figure Southeast Asia Induced Pluripotent Stem Cells Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Induced Pluripotent Stem Cells Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Induced Pluripotent Stem Cells Market Size Share by Players in 2016
Figure Southeast Asia Induced Pluripotent Stem Cells Market Size Share by Players in 2017
Figure Global Induced Pluripotent Stem Cells Market Size (Million USD) by Regions (2017-2022)
Table Global Induced Pluripotent Stem Cells Market Size (Million USD) by Regions (2017-2022)
Figure Global Induced Pluripotent Stem Cells Market Size Share by Regions in 2017
Figure Global Induced Pluripotent Stem Cells Market Size Share by Regions in 2022
Figure United States Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Induced Pluripotent Stem Cells Market Size (Million USD) by Type (2017-2022)
Figure Global Induced Pluripotent Stem Cells Market Size Share by Type in 2017
Figure Global Induced Pluripotent Stem Cells Market Size Share by Type in 2022
Table Global Induced Pluripotent Stem Cells Market Size (Million USD) by Application (2017-2022)
Figure Global Induced Pluripotent Stem Cells Market Size (Million USD) by Application in 2017
Figure Global Induced Pluripotent Stem Cells Market Size (Million USD) by Application in 2022
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
